Suppr超能文献

印度喀拉拉邦一个资源匮乏地区住院患者中与新冠病毒病相关死亡的直接原因及多种疾病的作用:基于记录的病例对照分析

Immediate cause and the role of multimorbidity in deaths associated with COVID 19 among hospitalized patients in a low resource district in Kerala India: A record-based case-control analysis.

作者信息

Vaman Raman Swathy, Valamparampil Mathew J, Dalmita Niya James, Reghukumar Aravind, Anish T S

机构信息

Scholar, ICMR School of Public Health, ICMR-National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Department of Health Services, Kerala, India.

出版信息

J Family Med Prim Care. 2023 Aug;12(8):1593-1601. doi: 10.4103/jfmpc.jfmpc_2061_22. Epub 2023 Aug 29.

Abstract

INTRODUCTION

Multimorbidity is the coexistence of two or more chronic medical conditions in a person. The study aims to investigate the immediate cause of death and risk factors of mortality including multimorbidity among patients hospitalized with SARS CoV2 infection in Kasaragod district in Kerala, India.

METHODS

A record-based case-control study was done using the hospital records and follow-up surveillance system of SARS-COV 2 patients admitted in the Kasaragod district. SARS-COV 2 patients who had expired during the study period from June to December 2020 and reported as COVID-19 deaths (N = 226) were the cases, and an equal number of hospital controls were the study participants.

RESULTS

The mean (SD) age of the cases and controls were found to be 64.6 (14.2) years and 61.5 (13.4) years, respectively. Covid pneumonia alone was reported as the cause of death in more than half (52%) of the study participants. This was followed by cardiovascular events (8.5%) and acute kidney injury (6.5%). Among individual comorbidities among people who expired, diabetes mellitus (53%) was the most common, followed by hypertension (46%) and cardiovascular diseases (23%). More than 50% were found to have multimorbidity. Logistic regression showed chronic kidney disease (CKD) (Adjusted odds ratio (AOR) = 2.18 (1.24-3.83)) and malignancy (AOR = 3.05 (1.27-7.32)) to be significantly associated with mortality as individual determinants. Hypertension-diabetes mellitus [AOR = 1.68 (1.02-2.76), = 0.043] and hypertension-CKD [AOR = 3.49 (1.01-12.01), = 0.48] dyads were multimorbidities significantly associated with mortality.

CONCLUSION

Combinations of hypertension with diabetes mellitus and CKD were found to be significant determinants for mortality in hospitalized COVID-19 patients. Uniformity in death certification is required to understand the causes and contributors to death in COVID-19.

摘要

引言

多病共存是指一个人同时患有两种或更多种慢性疾病。本研究旨在调查印度喀拉拉邦卡萨拉戈德地区因感染新冠病毒住院患者的直接死因以及包括多病共存在内的死亡风险因素。

方法

采用基于记录的病例对照研究,利用卡萨拉戈德地区收治的新冠患者的医院记录和随访监测系统。在2020年6月至12月研究期间死亡并报告为新冠死亡的患者(N = 226)为病例组,数量相等的医院对照为研究参与者。

结果

病例组和对照组的平均(标准差)年龄分别为64.6(14.2)岁和61.5(13.4)岁。超过一半(52%)的研究参与者报告单独的新冠肺炎为死因。其次是心血管事件(8.5%)和急性肾损伤(6.5%)。在死亡患者的个体合并症中,糖尿病(53%)最为常见,其次是高血压(46%)和心血管疾病(23%)。超过50%的患者存在多病共存情况。逻辑回归显示,作为个体决定因素,慢性肾脏病(CKD)(调整优势比(AOR)= 2.18(1.24 - 3.83))和恶性肿瘤(AOR = 3.05(1.27 - 7.32))与死亡率显著相关。高血压 - 糖尿病二元组[AOR = 1.68(1.02 - 2.76),P = 0.043]和高血压 - CKD二元组[AOR = 3.49(1.01 - 12.01),P = 0.048]是与死亡率显著相关的多病共存情况。

结论

高血压与糖尿病以及CKD的组合被发现是新冠住院患者死亡的重要决定因素。需要统一死亡证明以了解新冠死亡的原因和影响因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5503/10521846/048f679efd91/JFMPC-12-1593-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验